Impact Factor
2.81
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
1.82
139 total citations
h5-index
19
h5 depth signal
Cited share
59.0%
49 of 83
Total citations
139
Citation footprint
Metric signal
1.74
External metric anchor
Self-citation
1.4%
2 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
Japan
60
China
29
Italy
28
Portugal
24
United States
23
Citing Fields of Research
Oncology
119
Cancer & Development
81
Breast Cancer
56
Immunology
51
Lung Cancer
38
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
5,732
Articles tracked across the journal lifetime
Indexed publication set
83
49 cited publications
Last 12 months
30
2.7 publications/month
Open access share
26.7%
8 OA publications in the last year
Leading citing country
Japan
60 citing publications
Leading citing field
Oncology
119 citing publications
Latest tracked publication
16 October 2026
10 recent records available
Coverage & Indexing History
v58n1, 1990-
v58n1, 1990-
Active Coverage
Research Focus & Classification
Indexed Subjects
Oncology
Immunology
Cancer & Development
Lung Cancer
Breast Cancer
Urology
Broad Categories
Pathology
Breast Cancer
Hematology
Digestive Disorders
Lung Cancer
Lymphomas
Urology
Cancer & Development
MeSH Descriptors
Cells
Immunity
Molecular Biology
Pathology
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1159/pat/aehag008
Open DOI
Performance of Large Language Models Across Diagnostic Tasks in Oral and Maxillofacial Pathology: A Systematic Review
Introduction Large language models (LLMs) are increasingly evaluated for diagnostic applications; however, studies in oral and maxillofacial pathology (OMFP) assess materially different diagnostic tasks and outcomes. This systematic revi...
02
DOI 10.1159/pat/aehag006
Open DOI
Nectin-4 and TROP-2 in bladder cancer: biomarkers for targeted therapy
Bladder cancer is one of the most prevalent malignancies of the urinary system worldwide, with treatment strategies increasingly shifting towards precision and personalized medicine. Nectin-4 and TROP-2 are two membrane proteins highly e...
03
DOI 10.1159/pat/aehag009
Open DOI
Visualization and Interpretation of Nuclear Features in a Deep Learning-Discriminant Analysis of Lobular Endocervical Glandular Hyperplasia with VGG16 and Linear Support Vector Machine
Introduction: Lobular endocervical glandular hyperplasia (LEGH), which is considered a precursor lesion of gastric-type adenocarcinoma, exhibits subtle nuclear atypia in cytological specimens and, thus, is occasionally difficult to disti...
04
DOI 10.1159/pat/aehag004
Open DOI
Insights into the pathophysiology of post-COVID lung disease from the perspective of histopathology
The COVID-19 pandemic has caused a broad range of respiratory complications. Among the spectrum of COVID-associated pulmonary conditions, severe bilateral pneumonitis that might progress to acute respiratory distress syndrome (ARDS) repr...
05
DOI 10.1159/pat/aehag007
Open DOI
Transforming Growth Factor-ß Signaling in Glomerular Diseases: Mechanisms of Fibrosis and Therapeutic Perspectives
Background: Glomerular diseases are major drivers of chronic kidney disease (CKD) and end-stage renal failure worldwide. Transforming growth factor-β (TGF-β) is a central molecular regulator that integrates inflammatory, metabolic, and e...
06
DOI 10.1159/pat/aehag003
Open DOI
HLA-I loss in germ cell tumors of the testis: potential implications for immune evasion, preservation of the stem cell phenotype, and reprogramming
Introduction: Previous studies have analyzed the “reprogramming” of germ cell tumors of the testis (GCTT), which is a complex genetic/epigenetic process regulated by tumor microenvironment (TME) and resulting in the preservation of stem ...
07
DOI 10.1159/pat/aehag001
Open DOI
A Proof-of-Concept Study of Digital Spatial Distance Analysis in Ovarian Mature and Immature Teratomas
Introduction: Mature (MT) and immature teratomas (ITs) contain diverse histological components; however, their tissue-level spatial organization remains poorly understood. This proof-of-concept study aimed to develop a reproducible digit...
08
DOI 10.1159/pat/aehag002
Open DOI
Squamous Cells in the Thyroid Gland’s Cytopathology and Histopathology: Institutional Experience
Introduction: Squamous cells are a rare finding in the thyroid gland and have been reported in a wide range of entities, from benign cysts to carcinomas. This study presents the diagnostic outcomes and potential pitfalls associated with ...
09
DOI 10.1159/000553452
Open DOI
Activated Cancer-Associated Fibroblasts Are Associated with Immunosuppression and Poor Prognosis in Clear Cell Renal Cell Carcinoma
Introduction: Clear cell renal cell carcinoma (ccRCC) exhibits substantial heterogeneity within its tumor microenvironment, contributing to variable clinical outcomes. The prognostic significance and molecular characteristics of cancer-a...
10
DOI 10.1159/000553407
Open DOI
Targeted NGS-Based Mutational Signature Analysis in Hypermutated Gliomas: A Case-Centered Feasibility Assessment
Introduction: Gliomas generally display a low tumor mutational burden (TMB) and an immunosuppressive microenvironment, both of which restrict the effectiveness of immune checkpoint inhibitors. However, certain gliomas acquire a high TMB,...
Bibliographical & Catalog Notes
Bimonthly.
Called also v. 58, no. 1- .
Also available online.
Formed by the union of: Experimental cell biology, and: Pathology and immunopathology research.
Vol. 58, no. 1 (JAN-FEB 1990)19911012 Notice published Printed on acid-free paper